HB5682 is a supplemental appropriations bill that moves $35 million from the Governor’s Office – Civil Contingent Fund into the state’s General Revenue surplus balance and then allocates those funds to the Higher Education Policy Commission for fiscal year 2026. The bill increases the commission’s appropriation to $153,258,649 and specifies funding for a range of higher education programs, including personal services, current expenses, grant and scholarship programs, dual enrollment, system initiatives, facilities planning, and health-professions-related loan repayment and scholarship support.
A major feature of the bill is the earmarking of surplus funds for medical education and biomedical research expansion: $30 million for Marshall University School of Medicine, $32 million for the WVU School of Medicine, $5 million for the WVU Dental School, and $5 million for the West Virginia School of Osteopathic Medicine. The bill also directs certain appropriations to be transferred into dedicated funds, including the Higher Education Grant Fund, the Underwood-Smith Teaching Scholars Program Fund, the PROMISE Scholarship Fund, and the Military College Advisory Council Fund. It further reappropriates several unexpended balances from fiscal year 2025 for use in fiscal year 2026.
The bill’s impact on state law is primarily fiscal rather than regulatory: it amends the state’s appropriations for fiscal year 2026, authorizes the expiration of funds into surplus, and directs how those surplus dollars must be spent within higher education. It affects the Higher Education Policy Commission, state scholarship and grant programs, dual enrollment, medical and dental schools, and the West Virginia Regional Technology Park, while also reinforcing existing statutory funds referenced in the appropriation language.
The overall sentiment appears strongly favorable, as reflected by broad bipartisan support in both chambers and multiple unanimous or near-unanimous votes after amendment. The bill advanced quickly and was effective from passage, suggesting agreement on the need to deploy available surplus revenue for higher education priorities. The main point of contention appears to have been not whether to fund higher education, but how the money should be allocated and whether the Senate and House amendments should be accepted, as shown by the initial non-unanimous House votes before final concurrence.
Notable issues in the discussion and voting history include the large targeted investments in medical schools and biomedical research, the use of surplus general revenue rather than new taxes, and the transfer of funds into specific scholarship and grant accounts. The bill also references the dual enrollment program established in a prior bill, indicating that this appropriation supports an existing policy initiative rather than creating a new one.
HB5682 amends the state’s fiscal year 2026 appropriations by expiring $35 million from the Governor’s Office – Civil Contingent Fund into General Revenue surplus and then appropriating those funds to the Higher Education Policy Commission. It changes spending authority for multiple higher education programs, reappropriates certain unused balances from fiscal year 2025, and directs transfers into several statutorily created funds, including scholarship and grant funds. The bill primarily affects state budgeting and the distribution of public moneys rather than substantive regulatory law, with direct beneficiaries including public universities, scholarship recipients, dual enrollment participants, and health-professions training programs.
The bill appears to have enjoyed broad support across both chambers, with final passage votes unanimous in the Senate and strong majorities in the House. The voting pattern suggests general agreement that surplus revenue should be redirected to higher education and workforce-related programs, especially medical education and scholarship support. The few dissenting votes in earlier House action indicate some limited disagreement, but the final outcome reflects a largely positive and cooperative legislative posture toward the bill.
The main contention seems to have centered on the size and destination of the appropriations, particularly the large earmarks for Marshall University School of Medicine, WVU School of Medicine, WVU Dental School, and the West Virginia School of Osteopathic Medicine. There also appears to have been procedural or allocation-related disagreement reflected in the House’s initial non-unanimous votes and the Senate’s amended title, though the final concurrence votes were overwhelmingly favorable. No committee testimony is available, so the record does not show organized opposition from specific stakeholders, but the vote totals suggest the debate was more about appropriation structure than about the underlying purpose of funding higher education.